Search
for
Sort by
Research 271–300 of 728
- Cutaneous Reactions to Drugs
- Lipedematous Alopecia: Clinical, Histopathological, and Trichoscopic Findings of a Single Case and Review of the Literature
- Dermatologic Adverse Events from Cancer Treatments
- Chemotherapy and Cutaneous Drug Reactions
- Skin manifestations of chronic kidney disease
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Dermatologic manifestations of endocrine disorders
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Graft-versus-host disease
- Hair cosmetics
- Alternative uses of dermoscopy in daily clinical practice: An update
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Dermatologie care behind bars
- Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
- Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey among Dermatologists in Saudi Arabia
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Severe cardiac conduction abnormalities associated with atypical toxic shock syndrome
- Body Dysmorphic Disorder, Psychiatric Symptoms, and Quality of Life in Female Dermatological Patients
- Diseases of the Hair and Nails
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Case Report: Compound heterozygous variants in LSS and TSPEAR genes causing hypotrichosis type 14 complicated with ectodermal dysplasia type 14
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Cutaneous Lupus Erythematosus
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Mucocutaneous reactions to chemotherapy
- Severe cutaneous adverse reactions to drugs
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma